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facilitates tumor growth and promotes 
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Abstract 
Background and objective: Long non-coding RNAs can regulate tumorigenesis of various cancers. Dys-regulation 
of lncRNA-AFAP1-AS1 has not been studied in colorectal carcinoma (CRC). This study was to examine the function 
involvement of AFAP1-AS1 in tumor growth and metastasis of CRC.
Methods: Relative expression of AFAP1-AS1 in CRC tissues and CRC cells lines was determined using quantitative 
real-time PCR (qRT-PCR). Functional involvement of AFAP1-AS1 in tumor proliferation and metastasis was evaluated in 
AFAP1-AS1-specific siRNA-treated CRC cells and in CRC cell xenograft. Expression of epithelial-mesenchymal transition 
(EMT)-related gene expression was determined using western blot.
Results: Relative expression of AFAP1-AS1 was significantly elevated in CRC tissues and CRC HCT116 and SW480 cell 
lines. AFAP1-AS1 knock-down suppressed SW480 cell proliferation, colony formation, migration and invasion. Also 
AFAP1-AS1 knock-down inhibited tumor metastasis-associated genes expression in terms of EMT. This carcinostatic 
action by AFAP1-AS1 knock-down was further confirmed by suppression of tumor formation and hepatic metastasis 
of CRC cells in nude mice.
Conclusion: lncRNA-AFAP1-AS1 knock-down exhibits antitumor effect on colorectal carcinoma in respects of sup-
pression of cell proliferation and metastasis of cancer cells.
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Background
Colorectal carcinoma (CRC) is the third cause of can-
cer incidence and death worldwide [1]. Number of CRC 
patients is increasing in China. Although treatment 
methods have been improved, CRC still cannot be cure. 
Death occurs because of metastasis to other organ [2]. 
Elaboration of molecular pathogenesis underlying CRC 
may provide new therapeutic strategy.
Long non-coding RNAs (lncRNAs) are kind of RNA 
molecule with a length of longer than 200 nucleo-
tides and have no ability of coding protein [3]. As exist-
ing research results suggested that several lncRNAs are 
involved in transcriptional regulation, organization of 
nuclear structure, and post-transcriptional processing. 
Increasing evidences suggest that lncRNAs are involved 
in a larger range of cellular biological processes, including 
growth, proliferation and differentiation. Dysregulation 
of lncRNAs has been preliminary proved to contribute 
to carcinogenesis, invasion, and metastasis of various 
cancers [4–6]. However the function of most lncRNAs 
remains unclear. The identification of cancer-related 
lncRNAs and investigation of their molecular pathogen-
esis basis in cancers are important.
One lncRNA, actin filament associated protein 1 anti-
sense RNA1 (AFAP1-AS1), was the most significantly 
upregulated in pancreatic ductal adenocarcinoma, 
esophageal adenocarcinoma and lung cancer, and asso-
ciated with poor prognosis [7–9]. However the correla-
tion and functional involvement of AFAP1-AS1 in CRC 
remains unclear. The potential function of AFAP1-AS1 in 
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cancers is its regulatory role in tumor growth, invasion 
and metastasis. Tumor metastasis is a process of multi-
ple gene regulation cascades. Epithelial-to-mesenchymal 
transition (EMT) serves as a common biological mech-
anism underlying tumor progression [10, 11]. During 
EMT, epithelial cell lose its E-cadherin expression, which 
contributes to intercellular adhesion and enables cells 
with migratory and invasive properties. Increase expres-
sion of N-cadherin, Vimentin and Fibronectin can be 
markers for metastasis and poor prognosis [12–14]. EMT 
has been demonstrated to be a good target for various 
therapeutic interventions [15, 16].
In this study, we will compare expression of AFAP1-
AS1 in CRC tissues and paired adjacent non-cancerous 
tissues for purpose of identification of abnormal expres-
sion of AFAP1-AS1 in relation to tumorigenesis of CRC. 
The potential mechanism by which AFAP1-AS1 regulates 




Total 15 patients that have never received therapy before 
surgery were recruited from Affiliates Hospital of Beihua 
University in present study. Tissues were collected after 
acquirement of informed consent from patients. CRC tis-
sues and paired adjacent normal tissues were collected 
and rapid frozen in liquid nitrogen for subsequent real 
time PCR analysis. All protocols have been approved 
by Ethics Committee of Affiliates Hospital of Beihua 
University.
Colorectal carcinoma cell lines
Colorectal cancer cell lines HCT116 and SW480 were 
obtained from the ATCC and cultured in RPMI 1640 
(Hyclone) with supplement of 10 % FBS (Gibco-BRL; Inv-
itrogen) at a humidity of 5 % CO2 at 37 °C.
Quantitative real time PCR
Total RNA was extracted from colorectal tissues of 
CRC patients or CRC cells with Trizol Reagent (Qiagen, 
Hilden). Complementary DNA (cDNA) was synthe-
sized with equal 1 μg of total RNA by using superscript 
III reverse transcriptase (Invitrogen Life Technologies, 
Carlsbad, CA). One microliter of the cDNA was ampli-
fied by real time PCR for AFAP1-AS1 using Bio-Rad 
iCycler iQ Real-Time PCR Detection System (Bio-Rad 
Laboratories, Inc., Hercules, CA) with SYBR Green 
qPCR Super Mix (Invitrogen, Carlsbad, CA). Rela-
tive expression was calculated with the comparative Ct 
method and normalized against the Ct of β-Actin. The 
primers for qRT-PCR are as follows:AFAP1-AS1, For-
ward 5′-TCGCTCAATGGAGTGACGGCA-3′; Reverse 
5′-CGGCTGAGACCGCTGAGAACTT-3′; AFAP1, For-
ward 5′-AGAGTGTCCTCCTCCACCAA-3′ Reverse 5′-C 
TTGGCCTCTGATTTGGAAC-3′ GAPDH, Forward 5′- 
CACCCACTCCTCCACCTTTG-3′; Reverse 5′-CCA 
CCACCCTGTTGCTGTAG-3′.
Si‑AFAP1‑AS1 transfection
To knockdown AFAP1-AS1, the siRNA oligonucleo-
tides targeting AFAP1-AS1 and control (as mock 
indicated in manuscript) transfected into SW480 
cells using Lipofectamine RNAiMAX (Invitrogen, 
CA) according to the manufacturer’s protocols. The 
sequences of the AFAP1-AS1 targeting siRNAs were 
5′-GGGCTTCAATTTACAAGCATT-3′ (Si-RNA1) and 
5′-CCTATCTGGTCAACACGTATT-3′ (Si-RNA 2).
MTT assay
CRC cell proliferation was evaluated by MTT ([3-(4,5- 
dimethylthiazol-2-yl)-2,5 -diphenyltetrazolium bromide) 
assay. In brief, 1 × 104 cell/well cells were seeded in trip-
licate in 48-well plates and cultured in normal condition 
for 24 h under. Cells were transfected with si-AFAP1-AS1 
for 24 h for subsequent MTT assay with MTT cell pro-
liferation assay kit (Abnova, Walnut, CA), according to 
manufacturer’s protocols. Absorbance of each well was 
measured at 570  nm with a spectrophotometer (ELISA 
reader, Dynatech Laboratories, Chantilly, VA).
Colony formation
Cell in logarithmic phase was digested with 0.25  % 
trypsin and suspended in RPMI 1640 medium. A total of 
400 cells were uniformly inoculated into 10 ml petri dish 
and cultured in normal condition for 2 weeks till visible 
colon. Colons were then fixed with 4 % paraformaldehyde 
for 15 min for subsequent staining with GIMSA. Colony 
number was calculated under optical microscope.
Wound scratch assay
A total of 5 ×  105 cells were seeded in six-well culture 
plates and grown to 85–90  % confluence. Scratch was 
then vertically created by a p200 pipet tip in the cell 
monolayer. After a period of 24 h incubation in normal 
condition, images for cell growth around wounding were 
captured. Number of cell number around wounding cal-
culated and was normalized to Mock.
Transwell invasion assay
SW480 cell invasion capacity was assessed using Tran-
swell Chamber Cell Culture (10-μm pore membrane, 
BD Biosciences). A total of 1  ×  105 cells in 100  μl of 
serum-free medium were added to the top chamber of 
24-well plates that has been pre-added with Matrigel. 
The bottom well contained growth medium with 20  % 
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FBS. Transwell chambers were placed at 37 °C for 36 h. 
Cells in chamber were fixed with methanol for 30  min 
and then staining with Giemsa for 15–30  min. Invaded 
cells were finally observed under a microscope and the 
number was counted with randomly nine field for each 
experiment.
Western blot
Protein expression of N-cadherin, vimentin, Fibronectin 
E-cadherin and MMP-9 was performed with immunob-
lot analysis in cell lysates. After total protein quantifica-
tion by BCA kit, an equal quantity 30–40  μg protein of 
all samples was separated by 10  % sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS–PAGE), 
and then electrophoretic transferred onto PVDF mem-
brane. Membranes were experienced blockage with 5  % 
skim milk in TBS buffer, incubation with primary anti-
bodies for target gene, and subsequent incubation with 
horseradish peroxidase-conjugated secondary antibody. 
Between each step, membranes was washed with TBS 
suppled with 20 % Tween20. In the present experiment, 
anti-E-cadherin antibody, anti-N-cadherin antibody, 
anti-Vimentin antibody, anti-Fibronectin antibody and 
anti-MMP9 antibody were purchased from Cell Signaling 
Technology (Danvers, MA, USA); anti-GAPDH antibody 
and anti-AFAP1 antibody were purchased from Protein-
tech (Wuhan, China). The signal was finally visualized 
using an ECL detection reagent on Bio-Rad ChemiDoc 
MP. Visualization of GAPDH expression was used as a 
loading control.
Xenograft
Male C57BL/6 nude mice with 7-week-age were obtained 
from SLAC Laboratory Animals Co Ltd (Shanghai, 
China). Animals protocols have been approved by ani-
mal Ethics Committee of Affiliates Hospital of Beihua 
University and performed according to the institutional 
guidelines.
Subcutaneous tumor transplantation was performed 
by 106 of SW480 cells injection in the right flank of mice. 
Tumor was removed after 4  weeks transplantation and 
tumor weight was measured.
Hepatic metastasis of colonic carcinoma was per-
formed by 106 of SW480 cells injection into spleen of 
nude mice. Mice was euthanatized after 4  weeks injec-
tion. Hepatic metastasis nodules were then counted.
Statistical analysis
Statistical analysis was performed using SPSS software 
(version 16.0; Chicago, IL). Student’s t tests were used to 
evaluate significant differences between any two groups of 
data, or one-way analysis of variance with the Bonferroni 
post-test was performed for three or more comparisons. 
All data are represented as mean ± standard deviation. A 
p values <0.05 was considered significant.
Results
Abnormal expression of AFAP1‑AS1 in colorectal 
carcinoma
To determine the correlation between abnormal expres-
sion of AFAP1-AS1 and tumorigenesis of colorectal 
carcinoma, we examined relative expression of AFAP1-
AS1 in 15 clinical CRC tissues with paired para-carci-
noma tissue as control. As shown in Fig. 1a, AFAP1-AS1 
expressed significantly higher in CRC tissues than nor-
mal tissues. Moreover, relative expression of AFAP1-
AS1 was also elevated in CRC cells lines of HCT116 and 
SW480 (Fig. 1b).
Proliferation of colorectal carcinoma in AFAP1‑AS1 
knock‑down CRC cells
To explore the role of AFAP1-AS1 on CRC cell prolif-
eration, we examined cell proliferation in si-RNA1 or 
siRNA-2 transfected SW480. Si-AFAP1-AS1 transfec-
tion contributed to 5.9-fold decline of relative expres-
sion of AFAP1-AS1 in comparison to mock (Fig. 2a). This 
AFAP1-AS1 knock-down timely suppressed cell prolifer-
ation indicated by reduced OD values in si-RNA1-treated 
cells by MTT assay (Fig.  2b). In addition, AFAP1-AS1 
knock-down suppressed colony formation that substan-
tially reduced colony number (Fig. 2c).
Metastasis of colorectal carcinoma in AFAP1‑AS1 
knock‑down CRC cells
We next examined CRC cell migration and cell invasion 
in si-AFAP1-AS1 transfected SW480. Wound scratch 
assay was performed to gauge the effect of AFAP1-AS1 
knock-down on cell motility in Fig.  3a which showed 
wound recovery was significantly delayed in AFAP1-AS1-
specific siRNA-treated SW480 cells. The migrated cell 
Fig. 1 Relative expression of AFAP1-AS1 in a colorectal carcinoma 
(CRC) tissues (n = 15) and b colorectal carcinoma HCT116 and 
SW480 cell lines. ***P < 0.001 compared with normal tissues (paired 
para-carcinoma tissue) or normal colorectal cells
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was calculated and normalized to mock (Fig.  3b). Cell 
metastasis was assessed using invasion assays as shown 
in Fig.  3c in which cell migration was suppressed in 
AFAP1-AS1 knock-down SW480 cells. Cell migration 
was reduced by 51 % (Fig. 3d).
Inhibition of AFAP1‑AS1 in change of EMT associated gene 
expression
Epithelial to mesenchymal transition (EMT) is a 
tumor promotion process that mediates tumor inva-
sion and metastasis. We performed western blot to 
examine change of EMT associated gene expression 
in AFAP1-AS1-specific siRNA-treated SW480 cells in 
Fig.  4a which showed elevated E-cadherin and reduced 
N-cadherin, Vimentin and Fibronectin by si-AFAP1-
AS1. In addition, expression of matrix metalloproteinase 
(MMP) was inhibited (Fig. 4b).
Xenograft growth of AFAP1‑AS1 knock‑down SW480 cell
To investigate the function involvement of AFAP1-AS1 in 
growth of CRC cell xenograft, we subcutaneously trans-
planted the AFAP1-AS1-specific siRNA-treated SW480 
cells to nude mice for purpose of examination of tumor 
growth. Morphologic observation in Fig.  5a showed 
smaller xenograft of AFAP1-AS1 knock-down SW480 
cell than mock xenograft. By measurement of tumor 
weight, we observed that AFAP1-AS1 knock-down effec-
tively reduced 5.2-fold of tumor weight (Fig. 5b).
Hepatic metastasis of colonic carcinoma in AFAP1‑AS1 
knock‑down SW480 cell
To investigate the function involvement of AFAP1-AS1 
in hepatic metastasis of colonic carcinoma, we injected 
the AFAP1-AS1-specific siRNA-treated SW480 cells to 
spleen of nude mice for purpose of examination of num-
ber of metastasis nodules. Counting metastasis nodules 
was showed in Fig. 6a, in which AFAP1-AS1 knock-down 
caused decreased number of metastasis nodules com-
pared with mock.
Lnc‑AFAP1‑AS1 negatively regulates AFAP1 expression
We next detected the effect of lncRNA-AFAP1-AS1 on 
mRNA and protein level of AFAP1. As in Fig. 7, knock-
down Lnc-AFAP1-AS1 could promote the protein level 
of AFAP1 while having no effect on the mRNA level of 
AFAP1.
Fig. 2 Effect of AFAP1-AS1 knock-down on proliferation of colorectal carcinoma. a Si-AFAP1-AS1 including si-RNA1 and si-RNA2 transfection 
contributes downregulation of AFAP1-AS1 in comparison to mock (as control). b Cell proliferation by MTT assay and c colony formation were deter-
mined in si-RNA1-transfected SW480 cells. **P < 0.01, ***P < 0.001 compared with mock
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Discussion
We have set up a protocol to identify functional involve-
ment of lncRNA-AFAP1-AS1 in CRC tumorigenesis. Our 
data suggested that tissues and CRC cells expressed high 
level of AFAP1-AS1 and this upregulation correlated 
with CRC cell proliferation and metastasis. Previous 
studies have been suggested that AFAP1-AS1 serves as a 
promotor for other cancers. This present study was the 
first to define AFAP1-AS1 as a tumor promotor in CRC.
AFAP1-AS1 is recognized in recent years and was 
originally found in esophageal adenocarcinoma [8]. Since 
then researchers further explored its anti-cancer roles in 
other cancer, such as pancreatic ductal adenocarcinoma, 
nasopharyngeal carcinoma and hepatocellular carcinoma 
Fig. 3 Effect of AFAP1-AS1 knock-down on metastasis of colorectal carcinoma. a Image presents cell wound scratch assay. b Relative migrated 
cell was normalized to mock treated cells. c Image presents cell invasion. d Relative invasive cell was normalized to mock treated cells. **P < 0.01 
compared with mock
Fig. 4 AFAP1-AS1 knockdown promotes EMT. Western blot analysis 
determined expression a E-cadherin, N-cadherin, vimentin, Fibronec-
tin and b MMP-9 in si-RNA1-transfected SW480 cells
Fig. 5 Effect of AFAP1-AS1 knock-down on xenograft growth. SW480 
that has been transfected with si-AFAP1-AS1 or mock was subcuta-
neously injected nude mice. a Images presents tumor after 4 weeks 
transplantation. b Tumor weight was normalized to mock. ***P < 0.001 
compared with mock
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etc. [7, 17, 18], in which upregulation of AFAP1-AS1 
was associated with cancer poor prognosis and onco-
genesis. In keeping with these previous studies, our pre-
sent study showed that AFAP1-AS1 had the higher fold 
change in CRC tissues compared with paired adjacent 
normal tissues. We thus assessed AFAP1-AS1 function 
for CRC progression in CRC SW480 cells transfected 
with AFAP1-AS1-specific siRNA. Similar to expression 
in CRC tissues, AFAP1-AS1 was also enhanced in CRC 
HCT116 cells and SW480 cells. By AFAP1-AS1-specific 
siRNA (si-AFAP1-AS1) transfection, AFAP1-AS1 expres-
sion can reduce 56  % of mock treated SW480, and this 
AFAP-AS1 silencing resulted in suppression of CRC cell 
proliferation, indicating by MTT assay and colony forma-
tion assay. Anti-proliferation, a process that constituted 
basis of tumor growth by AFAP1-AS1 has been proved in 
previous study [19]. This data suggested anti-tumor for-
mation action of AFAP1-AS1 silencing.
Our in  vitro experiments also demonstrated that 
AFAP1-AS1 knockdown resulted in suppression of 
migration and invasion ability of CRC SW480 cells. 
Tumor metastasis is a multi-step process by which 
tumor cells disseminate form their primary site and form 
secondary tumor at a distant site. EMT is such a piv-
otal and intricate mediator in this process. The initially 
step of EMT process is E-cadherin suppression, thereby 
reduce cell adhesion. Our data showed that AFAP1-AS1 
knockdown caused enhancement of E-cadherin expres-
sion, providing an evidence of anti-metastasis action of 
AFAP1-AS1. Other migration related proteins that con-
trol the balance between cell–cell and cell-extracellular 
matrix adhesion, such as N-cadherin, Vimentin and 
Fibronectin [20], were also been positively regulated by 
AFAP1-AS1 silencing. Metalloproteinase-9 (MMP-9) 
belongs to a family of proteolytic enzymes that catalyze 
extracellular matrix (ECM) degradation and has a critical 
role in several stages of tumor progression [21]. Tumor 
metastasis commonly accompanied by increasing expres-
sion of MMP-9. We therefore examined the expression 
of MMP-9 in AFAP1-AS1 knock-down SW480 cells and 
observed downregulation of MMP-9. These data further 
confirmed the pro-metastasis role of AFAP1-AS1.
The anti-tumor action of AFAP1-AS1 silencing was 
confirmed by in  vivo mice-bearing tumor experiments. 
AFAP1-AS1-specific siRNA-treated SW480 cells were 
transplanted in the right flank or spleen of mice to evalu-
ate tumor growth and hepatic metastasis. Tumor for-
mation ability of AFAP1-AS1 silenced SW480 cells was 
significantly suppressed. Also hepatic metastasis ability of 
colonic carcinoma was substantially attenuated. In addi-
tion, we found that AFAP1-AS1 silencing could promote 
the expression level of actin filament-associated protein 
1 (AFAP1) protein, a binding partner for oncogenic Src 
[22], while having no effect on the level of AFAP1 mRNA. 
Our results are consistent with the previous study by Hao 
Bo et al. [17]. In this study, they found that AFAP1-AS1 
knockdown could induce the loss of stress filament integ-
rity and affect the expression of Rho/Rac GTPase family 
members and actin cytokeratin signaling pathway pro-
teins in nasopharyngeal cancer cells, so we speculate that 
AFAP1-AS1 knockdown could also affect actin cytoskel-
eton via small Rho GTPase in colorectal cancer cell, we 
will confirm it in the further study.
In conclusion, our data suggested that lncRNA-AFAP1-
AS1 was the tumor promotor of CRC and was associated 
with CRC cell proliferation and migration thereby con-
tributes to CRC tumor growth and metastasis. The pro-
cancer action of AFAP1-AS1 might be mediated by EMT 
process.
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